Ultragenyx Pharmaceutical Inc. RARE
$14.50
-1.83%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (13 Buy · 7 Hold · 0 Sell)
- Average Price Target
- $34.68
- Implied Upside
- +139.2%
- Price Target Range
- $16.00 – $90.00
- Analysts (12 mo)
- 20
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-21 | Evercore ISI GroupLiisa Bayko |
Maintains | In-line | $16 → $18 |
| 2026-09-21 | BarclaysEliana Merle |
Maintains | Overweight | $32 → $35 |
| 2026-09-18 | Morgan StanleyMaxwell Skor |
Maintains | Equal-weight | $18 → $20 |
| 2026-09-18 | CitigroupYigal Nochomovitz |
Maintains | Buy | $31 → $32 |
| 2026-09-18 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $37 → $39 |
| 2026-09-18 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $33 → $39 |
| 2026-09-17 | CitigroupYigal Nochomovitz |
Maintains | Buy | $28 → $31 |
| 2026-09-04 | Goldman SachsSalveen Richter |
Maintains | Neutral | $28 → $19 |
| 2026-09-04 | BarclaysEliana Merle |
Maintains | Overweight | $43 → $32 |
| 2026-09-03 | JP MorganAnupam Rama |
Downgrades | Overweight → Neutral | $80 → $36 |
| 2026-09-03 | JefferiesMaury Raycroft |
Maintains | Buy | $77 → $28 |
| 2026-09-03 | William BlairSami Corwin |
Downgrades | Outperform → Market perform | — |
| 2026-09-03 | CitigroupYigal Nochomovitz |
Maintains | Buy | $58 → $28 |
| 2026-09-03 | TD CowenYaron Werber |
Maintains | Buy | $49 → $18 |
| 2026-09-03 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $50 → $18 |
| 2026-09-03 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $83 → $37 |
| 2026-09-03 | WedbushLaura Chico |
Maintains | Neutral | $30 → $23 |
| 2026-09-03 | Evercore ISI GroupLiisa Bayko |
Downgrades | Outperform → In-line | $34 → $16 |
| 2026-09-03 | BairdJoel Beatty |
Downgrades | Outperform → Neutral | $40 → $16 |
| 2026-09-03 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $50 → $25 |
| 2026-09-03 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $103 → $33 |
| 2026-08-28 | Wells FargoMichael Turrin |
Maintains | Overweight | $46 → $50 |
| 2026-08-25 | JP MorganAnupam Rama |
Maintains | Overweight | $75 → $80 |
| 2026-08-21 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $67 → $74 |
| 2026-08-20 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $81 → $83 |
| 2026-08-20 | CitigroupYigal Nochomovitz |
Maintains | Buy | $45 → $58 |
| 2026-08-20 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $45 → $46 |
| 2026-08-20 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $96 → $103 |
| 2026-08-10 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $50 |
| 2026-08-05 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $47 → $45 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $14.50
- Market Cap
- $1.43 billion
- 52-Week Range
- $12.73 – $39.89
- Average Volume
- 5.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.